Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Other financing activities: 2019-2022

Historic Other financing activities for Avidity Biosciences (RNA) over the last 3 years, with Sep 2022 value amounting to $1.2 million.

  • Avidity Biosciences' Other financing activities fell 88.30% to $1.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $9.8 million, marking a year-over-year decrease of 71.37%. This contributed to the annual value of $17.1 million for FY2021, which is 29.01% down from last year.
  • As of Q3 2022, Avidity Biosciences' Other financing activities stood at $1.2 million, which was up 2.70% from $1.2 million recorded in Q2 2022.
  • Over the past 5 years, Avidity Biosciences' Other financing activities peaked at $22.5 million during Q2 2020, and registered a low of $10,000 during Q2 2021.
  • Over the past 3 years, Avidity Biosciences' median Other financing activities value was $1.2 million (recorded in 2022), while the average stood at $4.9 million.
  • Per our database at Business Quant, Avidity Biosciences' Other financing activities plummeted by 99.96% in 2021 and then soared by 11,740.00% in 2022.
  • Over the past 4 years, Avidity Biosciences' Other financing activities (Quarterly) stood at $17,000 in 2019, then reached $1.3 million in 2020, then spiked by 671.84% to $6.7 million in 2021, then tumbled by 88.30% to $1.2 million in 2022.
  • Its last three reported values are $1.2 million in Q3 2022, $1.2 million for Q2 2022, and $745,000 during Q1 2022.